101 |
Eisai Co. Ltd. et al. v. Lupin Ltd., et al. |
1:13-cv-01281 |
D.Del. |
|
|
|
|
102 |
Eisai Co. Ltd. et al. v. Lupin Ltd., et al. |
1:13-cv-01281 |
D.Del. |
|
|
|
|
103 |
Eisai Co. Ltd. et al. v. Lupin Ltd., et al. |
1:13-cv-01281 |
D.Del. |
|
|
|
|
104 |
Cephalon, Inc. et al v. Lupin Limited et al |
1:10-cv-00661 |
D.Md. |
|
|
|
|
105 |
Cephalon, Inc. et al v. Lupin Limited et al |
1:10-cv-00661 |
D.Md. |
|
|
|
|
106 |
Cephalon Inc. et al v. Lupin Limited et al |
1:10-cv-00210 |
D.Del. |
|
|
|
|
107 |
Cephalon Inc. et al v. Lupin Limited et al |
1:10-cv-00210 |
D.Del. |
|
|
|
|
108 |
Bristol-Myers Squibb & Gilead Sciences, LLC v. Lupin Ltd. |
2:14-cv-00795 |
E.D.Tex. |
|
|
|
|
109 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
110 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
111 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
112 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
113 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
114 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
115 |
Aventis Pharma Deutschland GMBH et al v. Lupin Ltd. et al |
2:05-cv-00421 |
E.D.Va. |
|
|
|
|
116 |
Aventis Pharma Deutschland GmbH et al v. Lupin Ltd. et al |
1:05-cv-01936 |
D.Md. |
|
|
|
|
117 |
Aventis Pharma Deutschland GmbH et al v. Lupin Ltd. et al |
1:05-cv-01936 |
D.Md. |
|
|
|
|
118 |
Aventis Pharma Deutschland GMBH et al v. Lupin Ltd. et al |
2:05-cv-00421 |
E.D.Va. |
|
|
|
|
119 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
120 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
121 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
122 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
123 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
124 |
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al |
1:18-cv-01606 |
D.Del. |
|
|
|
|
125 |
Allergan, Inc. v. Lupin Ltd. et al |
6:11-cv-00611 |
E.D.Tex. |
|
|
|
|
126 |
Alcon Research, Ltd. v. Watson Laboratories, Inc., et al., |
1:15-cv-01159 |
D.Del. |
|
|
|
|
127 |
Alcon Pharmaceuticals Ltd et al v. Lupin Ltd. et al |
1:12-cv-00973 |
D.Del. |
|
|
|
|
128 |
Alcon Pharmaceuticals Ltd et al v. Lupin Ltd. et al |
1:12-cv-00973 |
D.Del. |
|
|
|
|
129 |
ABBOTT LABORATORIES et al v. LUPIN LIMITED et al |
2:09-cv-01007 |
D.N.J. |
|
|
|
|
130 |
ABBOTT LABORATORIES et al v. LUPIN LIMITED et al |
2:09-cv-01007 |
D.N.J. |
|
|
|
|